Augmont Enterprises Reports IPO Proceeds Utilization for Q2 FY27 Monitoring Period
Augmont Enterprises Ltd · Others (Uncategorized) · 06 Nov 2026, 5:18 pm
Augmont Enterprises Reports IPO Proceeds Utilization for Q2 FY27 Monitoring Period CARE Ratings confirmed zero material deviation in Augmont Enterprises' utilization of its ₹620.00 crore fresh IPO proceeds for the quarter ended 30th Sep'26. The company deployed ₹573.40 crore during the period, comprising ₹465.23 crore for working capital requirements (gold and silver procurement), ₹107.76 crore for general corporate purposes, and ₹0.41 crore toward offer expenses. The unutilized balance of ₹46.60 crore is maintained in HDFC Bank's public offer account, with remaining issue-related expenses slated for settlement by end-Dec'26.
Original exchange filing (PDF)
More announcements from Augmont Enterprises Ltd
- Transcript of Earnings Conference Call with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 11 Nov 2026
- Audio Recording of virtual Earnings Conference Call with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 06 Nov 2026
- Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find .... · 05 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), as amended from time to time, please find enclosed herewith, .... · 05 Nov 2026
- Submission of Statement of Deviation of proceeds of IPO, as prescribed under Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) .... · 05 Nov 2026
- Augmont Enterprises Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Approval of Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2026. · 05 Nov 2026
- Outcome of the Board Meeting held on 04th November 2026. · 05 Nov 2026
